Fred Alger Management’s NewAmsterdam Pharma NAMS Stock Holding History

Fred Alger Management’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Sell	45,115 -9,080	-17%	-$299K	0.01%	336
2026 Q1	$1.73M	Buy	54,195 +6,660	+14%	+$217K	0.01%	329
2025 Q4	$1.67M	Buy	47,535 +6,271	+15%	+$228K	0.01%	324
2025 Q3	$1.17M	Buy	41,264 +19,227	+87%	+$461K	﹤0.01%	353
2025 Q2	$399K	Sell	22,037 -5,384	-20%	-$98.2K	﹤0.01%	392
2025 Q1	$561K	Sell	27,421 -53,158	-66%	-$1.18M	﹤0.01%	354
2024 Q4	$2.07M	Buy	+80,579	New	+$1.71M	0.01%	327

Other funds holding NAMS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Fred Alger Management's NAMS Position: Q2 2026 in Review

Fred Alger Management reduced its NewAmsterdam Pharma (NAMS) stake by 17% in Q2 2026, selling an estimated $299K and leaving 45,115 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #336.

Fred Alger Management first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.07M in Q4 2024. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

Fred Alger Management held 45,115 shares of NewAmsterdam Pharma worth $1.53M as of Q2 2026.
Fred Alger Management sold 9,080 NewAmsterdam Pharma shares in Q2 2026, an estimated $299K.
NewAmsterdam Pharma made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #336 holding.
Fred Alger Management first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
Fred Alger Management's NewAmsterdam Pharma position peaked at $2.07M in Q4 2024.
194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.